PsychPlus

What PsychPlus does

PsychPlus is a US-based mental health care provider operating a hybrid in-person and virtual care model through more than 200 clinical locations across all 50 states. Its service portfolio spans standard outpatient psychiatry and therapy (individual, couples/family, and group) as well as high-acuity interventional treatments including transcranial magnetic stimulation (TMS), Spravato (esketamine), electroconvulsive therapy (ECT), intensive outpatient programs, partial hospitalization programs, psychiatric urgent care, and alcohol/substance detox. The technology layer consists of a proprietary electronic health record system and a mobile application on iOS and Android that enables 24/7 self-scheduling, virtual waiting rooms, patient portal access, and integrated care delivery across in-person and telehealth channels.

The company generates revenue primarily through fee-for-service clinical care billed to insurance plans and patients, accepting most major US payors including United Healthcare, Aetna, Cigna, Empire, Humana, Medicaid, and Medicare. Its go-to-market combines a direct-to-consumer acquisition motion (website, mobile app, self-scheduling, referrals) with B2B partnerships across employers and EAPs, health plans, behavioral health hospitals, acute hospitals, ACOs/CINs, FQHCs/CMHCs, schools, government agencies, long-term care facilities, workers' compensation programs, and provider practice groups. Pricing is insurance-led with quote-based self-pay for uninsured patients and no publicly disclosed subscription tiers.

In June 2026, PsychPlus acquired Koa Health, a digital mental health company, positioning the combined entity as what PsychPlus describes as the world's largest technology-enabled mental health company. The acquisition added a digital-first care delivery model, 23 peer-reviewed clinical studies, 56 patents, and reach into Europe, Australia, and Asia-Pacific, bringing reported patient coverage to more than 6 million globally. The company was founded in 2018 by Dr. Faisal Tai, MD and is headquartered in Houston, Texas, with leadership now including President Oliver Harrison.

Name

PsychPlus

Legal name

PsychPlus

Website

https://psychplus.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

501–1,000 employees

Short description

PsychPlus operates 200+ mental health clinics across all 50 US states, delivering psychiatry, therapy, and interventional treatments (TMS, Spravato, ECT) via a proprietary EHR and mobile app. Following its 2026 Koa Health acquisition, the platform serves 6 million+ patients globally.

Ownership category

akta.pro rank

Product category

Mental Health Care Services

NAICS

Offices of Physicians, Mental Health Specialists (621112), Offices of Mental Health Practitioners (except Physicians) (62133), Psychiatric and Substance Abuse Hospitals (62221)

SIC

Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Psychiatry & Medication Management Platforms (HLALAEAB)

Keywords

• Mental health care
• Psychiatry services
• Behavioral health treatment
• Telehealth therapy
• Psychiatric urgent care

Headquarters

HQ city

Houston

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Patient Care Services: PsychPlus generates revenue through providing mental health care services including psychiatry, therapy, medication management, and specialized treatments (TMS, Spravato, ECT). Services are billed to insurance plans and patients directly.

Pricing tiers

Go-to-market motion1 record

Distribution channels6 records

Marketing channels8 records

Core offering

PsychPlus is a mental health care provider that delivers psychiatric evaluation, medication management, and therapy services through licensed psychiatrists, nurse practitioners, and therapists across 200+ US clinical locations and via telehealth. The service portfolio includes individual, couples/family, and group therapy, plus specialized interventional treatments such as Spravato, TMS, ECT, intensive outpatient programs, partial hospitalization, psychiatric urgent care, and substance detox. Patients self-schedule 24/7 online or via mobile app with same-day and next-day appointment availability, with most major insurance plans accepted.

Product overview

PsychPlus is a mental healthcare provider offering a comprehensive ecosystem of in-person and virtual care services through licensed psychiatrists, therapists, and nurse practitioners. The core offering includes psychiatry services and talk therapy (individual, couples/family, and group), supported by specialized treatment programs including Spravato (esketamine), TMS (transcranial magnetic stimulation), ECT, Intensive Outpatient Program (IOP), Partial Hospitalization Program (PHP), Psychiatric Urgent Care, and substance detox services. The company operates a clinical network of over 200 US locations and serves more than 6 million patients following its acquisition of Koa Health. Technology infrastructure includes a proprietary EHR system and a mobile application for patient self-scheduling and virtual care access. The platform also offers digital-first care delivery integrated with the clinical network.

Differentiator

Problem solved

Functional benefit

Products and services

• Psychiatry Services Psychiatric evaluation, diagnosis, and medication management services provided by licensed psychiatrists for mental health conditions.
• Therapy Individual talk therapy sessions provided by licensed therapists and counselors for various mental health concerns.
• Couples/Family Therapy Therapeutic services addressing relationship dynamics, family conflicts, and improving communication among couples and family members.
• Group Therapy Therapeutic sessions conducted in group settings allowing patients to share experiences and learn from others facing similar challenges.
• Spravato (Esketamine Treatment) FDA-approved esketamine nasal spray treatment for treatment-resistant depression, administered under medical supervision.
• TMS (Transcranial Magnetic Stimulation) Non-invasive brain stimulation therapy using magnetic fields to stimulate nerve cells for treating depression and other mental health conditions.
• Intensive Outpatient Program (IOP) Structured treatment program providing multiple therapy sessions per week while allowing patients to live at home.
• Partial Hospitalization Program (PHP) Day treatment program providing intensive therapeutic care with clinical support, offering a step down from inpatient hospitalization.
• Psychiatric Urgent Care Immediate psychiatric evaluation and care for mental health crises without the need for emergency room visits.
• ECT (Electroconvulsive Therapy) Medical procedure involving electrical stimulation of the brain under anesthesia for severe mental health conditions.
• Detox: Alcohol and Substance Treatment Medical detoxification and substance abuse treatment services for alcohol and drug dependency.
• PsychPlus Mobile App Mobile application enabling patients to self-schedule appointments, access virtual care, view medications, and manage their mental health care on-the-go.

Quantifiable outcome

• More than 6 million patients supported across 4 continents

Named customers10 records

Segments13 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Koa HealthflagshipStrategic or Co-development Partner · 23 June 2026PsychPlus acquired Koa Health to create the world's largest technology-enabled mental health company. The acquisition combined PsychPlus's clinical network of 200+ US locations with Koa Health's digital-first care delivery model. The merged entity now supports over 6 million patients. Koa Health brings 23 peer-reviewed clinical studies and 56 patents to the platform, enhancing PsychPlus's evidence-based care capabilities and international reach in Europe, Australia, and Asia-Pacific.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Cerebral: Cerebral is a telehealth mental health platform offering online psychiatry and therapy with medication management, overlapping directly with PsychPlus's core psychiatry + therapy model.
• Talkspace: Talkspace is an online therapy and psychiatry platform serving both consumers and B2B partners including employers and health plans, with a similar D2C-plus-enterprise GTM motion to PsychPlus.
• Talkiatry: Talkiatry is a national in-network telepsychiatry group, directly comparable to PsychPlus in offering insurance-accepted, psychiatrist-led outpatient mental health care at scale.
• Lyra Health: Lyra Health is a mental health benefits platform for employers and health plans combining therapy, coaching, and psychiatry - a direct B2B competitor to PsychPlus's employer/EAP channel.
• Headway: Headway is a network and software platform that helps mental health providers accept insurance and grow practices, competing with PsychPlus on the provider-network and insurance-accepting dimension.
• Two Chairs: Two Chairs operates hybrid in-person and virtual therapy clinics in multiple US markets with insurance acceptance, comparable to PsychPlus's in-person + virtual therapy model.
• Array Behavioral Care: Array Behavioral Care is a telepsychiatry provider serving acute hospitals, emergency departments, and inpatient facilities, directly comparable to PsychPlus's hospital/ED consultation services.
• LifeStance Health: LifeStance Health is one of the largest US outpatient mental health provider groups with in-person and telepsychiatry services, competing head-to-head with PsychPlus on physical scale and insurance participation.
• Brightside Health: Brightside Health is a telehealth psychiatry and therapy platform focused on anxiety and depression with medication management, overlapping PsychPlus's psychiatry-led service line.

Broad incumbents

• Headspace Health: Headspace Health (Headspace plus Ginger) is a broader digital mental health and wellness platform with employer/B2B reach, an adjacent incumbent with overlapping employer mental health channels but a more consumer/digital orientation than PsychPlus.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/PsychPlus.mindyourhealth
• LinkedInlinkedin.com/company/psychplus
• Instagraminstagram.com/psychplusonline

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PsychPlus